MorphoSys Strengthens European Patent Position on Anti-CD19 Cancer Program MOR208

News   Dec 03, 2013

 
MorphoSys Strengthens European Patent Position on Anti-CD19 Cancer Program MOR208
 
 
 

RELATED ARTICLES

Psoriasis Drug Also Reduces Aortic Inflammation

News

An antibody used to treat the autoimmune skin disease psoriasis is also effective at reducing aortic inflammation, a key marker of future risk of major cardiovascular events.

READ MORE

Computational Model Underlines Need for Personalised Approach to Sepsis

News

A computational model of the human immune system has enabled researchers to explore the challenges of tackling sepsis.

READ MORE

Drug Transport Gene May Explain Why Ovarian Cancer Patients React Differently to Chemotherapy

News

A gene which produces a protein that transports drugs in and out of cells may explain why some women treated with chemo have serious side effects.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE